Assura Deliver strong performance enhanced by growing development

DirectorsTalk Interviews FTSE 250

Assura plc (LON: AGR), the leading primary care property investor and developer, has announced its interim results for the 6 months to the 30th September 2019. Jonathan Murphy, Assura CEO, said: “Assura has today delivered another strong performance, driven by new developments and carefully selected acquisitions. We have again made good progress with our key operational metrics, reporting 10% growth …

Vodafone executing on strategic priorities

DirectorsTalk Interviews FTSE 100

Vodafone (LON:VOD) has announced its results for the six months ended 30 September 2019. Financial highlights H1 organic service revenue up 0.3%* as Q2 returned to growth (Q1: -0.2%, Q2: +0.7%), supported by improvements in South Africa, Spain and Italy, with solid retail performance in Germany and strong commercial acceleration in the UK. Organic adjusted EBITDA up 1.4%*, reflecting €0.2 …

AstraZeneca presents results from the positive Phase III TULIP 2 trial for anifrolumab

DirectorsTalk Interviews FTSE 100

AstraZeneca (LON:AZN) has presented detailed results from the positive Phase III TULIP 2 trial for anifrolumab, a potential new medicine for the treatment of moderate to severe systemic lupus erythematosus (SLE), which demonstrated superiority across multiple efficacy endpoints versus placebo, with both arms receiving standard of care. On the primary endpoint, anifrolumab achieved a statistically significant and clinically meaningful reduction in …

Domino’s Pizza Group plc Appoint Usman Nabi to the Board

DirectorsTalk Interviews FTSE 250

Domino’s Pizza Group (LON: DOM) has announced the appointment of Usman Nabi to the Board as Non-Executive Director and a member of the Nomination Committee, with effect from the 11th November 2019. Usman will work alongside Ian Bull, the Company’s Senior Independent Director, in seeking to recruit a new Chairman, a process that will be overseen by the Nomination Committee. …

DCC reports strong first half performance

DirectorsTalk Interviews FTSE 100

DCC (LON:DCC), the leading international sales, marketing and support services group, has announced its results for the six months ended 30 September 2019. Highlights 2019 2018 % change Revenue £7.312bn £7.418bn -1.4% Adjusted operating profit1,2 £162.6m £141.9m +14.5% DCC LPG £49.0m £40.9m +19.8% DCC Retail & Oil £59.7m £56.3m +6.0% DCC Technology £25.4m £17.8m +42.6% DCC Healthcare £28.5m £26.9m +5.8% …

Persimmon Plc and OnTheMarket sign listing agreement

DirectorsTalk Interviews FTSE 100

OnTheMarket plc (LON: OTMP), the agent-backed company which operates the OnTheMarket.com property portal, has announced that it has signed a listing agreement with Persimmon Plc (LON: PSN), one of the UK’s leading house builders. Under the agreement, which covers listing and additional advertising products, Persimmon Plc will list all its residential developments at OnTheMarket from both its Persimmon and Charles …

Greggs PLC

Greggs Strong Q4 with Sales up 12.4%

DirectorsTalk Interviews FTSE 250

Greggs plc (LON: GRG) a leading UK food-on-the-go retailer, with more than 2,000 retail outlets throughout the country has provided a trading update for the six weeks to the 9th November 2019. · Total sales up 12.4% for the six weeks to 9 November 2019 · Company-managed shop like-for-like sales up 8.3% for the six weeks to 9 November 2019 …

Kainos Group Acquires Formulate and Implexa

DirectorsTalk Interviews FTSE 250

Kainos Group (LON: KNOS), a leading UK-based provider of digital services and platforms, has announcd further investment into Adaptive Insights’ UK and European markets through the acquisitions of Formulate Limited and the Adaptive Insights arm of Implexa GmbH. Formulate is a leading UK and European partner to Adaptive Insights: a financial and business planning software business which is part of …

Rightmove PLC

Rightmove plc CFO Robyn Perriss steps down

DirectorsTalk Interviews FTSE 100

Rightmove plc (LON: RMV) announced that Robyn Perriss has informed the Board that she intends to step down as Finance Director of the Group. This will occur at a date to be agreed in due course, but is expected to be during Q2 2020. Robyn will continue to act as Finance Director for the Group over the coming months and …

AstraZeneca PLC Roxadustat pooled analyses: no increased CV risk

DirectorsTalk Interviews FTSE 100

AstraZeneca (LON: AZN) and FibroGen Inc. have presented pooled efficacy and cardiovascular safety analyses from the pivotal Phase III programme assessing roxadustat for the treatment of patients with anaemia from chronic kidney disease. The pooled CV safety analyses showed that roxadustat, an oral first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), did not increase the risk of MACE, MACE+ and all-cause …